Suchergebnisse - "Hyngstrom, John"

PubPharm (65)

1

Tumor Lysate Particle Only Vaccine (TLPO) vs. Tumor Lysate Particle-Loaded, Dendritic Cell Vaccine (TLPLDC) to Prevent Recurrence in Resected Stage III/IV Melanoma Patients: Results of a Phase I/IIa Trial

enthalten in: ResearchSquare.com | 2024

von Decar, S. | Carpenter, E. | Adams, A. | +21

2

Single-Photon Emission Computed Tomography/Computed Tomography Utilization for Extremity Melanomas at a High-Volume Center

enthalten in: The Journal of surgical research | 2024

von Fastner, S. | Creveling, P. | Shen, N. | +4

3

Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma

enthalten in: Journal for immunotherapy of cancer | 2024

von Kovacsovics-Bankowski, M. | Sweere, J. | Healy, C. | +17

4

Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma : A Randomized Clinical Trial

enthalten in: JAMA oncology | 2023

von Dummer, R. | Gyorki, D. | Hyngstrom, J. | +3

5

Anorectal melanoma

enthalten in: Journal of surgical oncology | 2023

von Fastner, S. | Hieken, T. | McWilliams, R. | +1

6

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma : a prespecified 36-month analysis

enthalten in: Journal for immunotherapy of cancer | 2023

von Carpenter, E. | Van Decar, S. | Adams, A. | +22

7

Regarding : Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma

enthalten in: Annals of surgical oncology | 2023

von Thompson, J. | Hyngstrom, J. | Caracò, C. | +44

CommentOn: Ann Surg Oncol. 2022 Dec;29(13):8469-8477. - PMID 35989390

8

Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma

enthalten in: Melanoma research | 2023

von Brunsgaard, E. | Bowles, T. | Asare, E. | +9

9

Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma : a retrospective analysis

enthalten in: Research square | 2023

von Williamson, J. | Fadlullah, M. | Kovacsovics-Bankowski, M. | +16

10

Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma

enthalten in: Annals of surgical oncology | 2023

von Thompson, J. | Hyngstrom, J. | Caracò, C. | +44

1
2
3
4
5
6
7
Nächster »
[7]